NERVGEN PHARMA CORP. Total Equity

by

Quick Answer

NERVGEN PHARMA CORP. reported total equity of C$3.48 million for fiscal year 2025 (IFRS, Form 20-F).

Reported under IFRS (SEC Form 20-F). Figures are shown in USD where the company provided them, otherwise in its reporting currency — each value exactly as filed with the SEC, not converted.

NERVGEN PHARMA CORP. Total Equity — Annual History

Fiscal Year Total Equity YoY Change
2025 C$3.48M +34.9%
2024 C$2.58M +228.2%
2023 -C$2.01M —
  • NERVGEN PHARMA CORP.’s total equity rose 34.9% year over year.
  • The most recent figure is from NERVGEN PHARMA CORP.’s fiscal year 2025 annual report (Form 20-F), filed March 31, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 19, 2026.

Last verified:

Leave a Comment